Corporate Updates

Adoption of HL7 CDA to connect clinical trial data and EHRs

Health Level Seven® International (HL7®) announced today a collaborative effort with the National Cancer Institute (NCI) to use HL7 Clinical Document Architecture (CDA®) in a unique way that solves the problem of connecting clinical trial data to patients’ electronic health records (EHRS). The new collaboration was announced at the 2012 HIMSS Annual Conference and Exhibition, ranked as one of the largest health information technology conferences in the United States.

“This is a significant advance in HIT connectivity because it brings clinical trial data directly to patients’ personal physicians, which means we can improve patient care by speeding the process of moving medical advances from bench to bedside,” said Robert Dolin, MD FACP, vice chair of the HL7 Board of Directors and co-editor of the CDA.  “Studies have shown that right now it can take seven years or more for new research advances to be put into clinical practice.  We can make that process much quicker by improving physician access to clinical trial data, and by expressing clinical trial data using meaningful use EHR standards.”

The new project demonstrates that clinical trial data can be packaged using the same HL7 standards that are incorporated into EHRs that meet the Stage 1 meaningful use criteria of the U.S. Office of the National Coordinator (ONC) to bring clinical trial data directly to the point of care and facilitate data analysis. Physicians will have a more complete picture of the care provided to their patients during clinical trials, and the project will also help facilitate data analysis that may speed the availability of new treatments to patients.

Click to comment

Leave a Reply

Your email address will not be published.

Most Popular





Get Heard Portal


eHealth Event Report



To Top